Abstract:Apathy is a common and disabling complication of Parkinson's disease characterised by reduced goal-directed behaviour. Several studies have reported dysfunction within prefrontal cortical regions and projections from brainstem nuclei whose neuromodulators include dopamine, serotonin and noradrenaline. Work in animal and human neuroscience have confirmed contributions of these neuromodulators on aspects of motivated decision making. Specifically, these neuromodulators have overlapping contributions to encoding the value of decisions, and influence whether to explore alternative courses of action, or persist in an existing strategy to achieve a rewarding goal. Building upon this work, we hypothesised that apathy in Parkinson's disease should be associated with an impairment in value-based learning. Using a four-armed restless bandit reinforcement learning task, we studied decision making in 75 volunteers; 53 patients with Parkinson's Disease, with and without clinical apathy, and 22 age matched healthy controls. Patients with apathy exhibited impaired ability to choose the highest value bandit. Task performance predicted an individual patient's apathy severity measured using the Lille Apathy Rating scale (R = -0.46, p<0.001). Computational modelling of the patient's choices confirmed the apathy group made decisions that were indifferent to the learnt value of the options, consistent with previous reports of reward insensitivity. Further analysis demonstrated a shift away from exploiting the highest value option and a reduction in perseveration which also correlated with apathy scores (R = -0.5, p<0.001). We went on to acquire fMRI in 59 volunteers; a group of 19 patients with and 20 without apathy and 20 age matched controls performing the restless bandit task. Analysis of the fMRI signal at the point of reward feedback confirmed diminished signal within ventromedial prefrontal cortex in Parkinson's disease, which was more marked in apathy, but not predictive of their individual apathy severity. Using a model-based categorisation of choice type, decisions to explore lower value bandits in the apathy group activated prefrontal cortex to a similar degree to the age-matched controls. In contrast, Parkinson's patients without apathy demonstrated significantly increased activation across a distributed thalamo-cortical network. Enhanced activity in the thalamus predicted individual apathy severity across both patient groups and exhibited functional connectivity with dorsal anterior cingulate cortex and anterior insula. Given that task performance in patients without apathy was no different to the age-matched controls, we interpret the recruitment of this network as a possible compensatory mechanism, which compensates against symptomatic manifestation of apathy in Parkinson's disease.

Greater Apathy Associated With Selective Serotonin Reuptake Inhibitor Use in Parkinson's Disease

Apathy associated with antidepressant drugs: a systematic review

Apathy in Drug-Naïve Patients with Parkinson's Disease

Analysis of Influencing Factors of Apathy in Patients with Parkinson's Disease.

Multiple sleep disturbances are associated with apathy in individuals with Parkinson's disease

Cross-Sectional and Longitudinal Association of Clinical and Neurocognitive Factors With Apathy in Patients With Parkinson Disease

Apathy in Parkinson's Disease: Defining the Park Apathy Subtype

Evolution of Apathy in Early Parkinson's Disease: A 4-Years Prospective Cohort Study

Apathy in Parkinson's Disease: Clinical Patterns and Neurobiological Basis

A Cognitive‐Behavioral Model of Apathy in Parkinson's Disease

Impulse Control Behaviors and Apathy Commonly Co-Occur in De Novo Parkinson's Disease and Predict the Incidence of Levodopa-Induced Dyskinesia.

Treatment of Apathy in Parkinson's Disease and Implications for Underlying Pathophysiology

Impaired value-based decision-making in Parkinson's disease apathy

Excessive Iron and Α-Synuclein Oligomer in Brain Are Relevant to Pure Apathy in Parkinson Disease.

Apathy in Parkinson's disease: clinical features, neural substrates, diagnosis, and treatment

Abnormal Spontaneous Neural Activity in Parkinson’s Disease With “pure” Apathy

Noradrenergic Deficits Contribute to Apathy in Parkinson’s Disease Through the Precision of Expected Outcomes

Apathy is Associated with Critical Psychological Determinants of Medication Adherence in HIV Disease

Apathy in Lewy body disease and its effects on functional impairment over time

Relationship between emotional apathy and motor symptoms, sleep and cognitive function in patients with early Parkinson′s disease

Apathy in persons living with HIV disease: A systematic narrative review